MetLife Inc

MET remains in a Stage 2 advancing regime, but a recent blow-off top on heavy volume and extreme overbought conditions make short-term timing unfavorable. Defer buying into a shallow pullback toward the rising 9 and 21 EMA support zone for structurally defined entry.

• ↑Q1 adjusted earnings $1.6 B, EPS $2.42, up 23% YoY
• ↑Returned $1.1 B to shareholders in Q1 via buybacks and dividends
• ↓Profitability challenges persist as higher claims erode margins